Fig. 1From: Survival outcomes of adjuvant taxanes, platinum plus fluoropyrimidines versus platinum and fluoropyrimidines for gastric cancer patients after D2 gastrectomy: a retrospective propensity score-matched analysisFlowchart of data selection. 1st Affiliated Hospital of AHMU, The First Affiliated Hospital of Anhui Medical University (China); PF, platinum plus fluoropyrimidines; TPF, taxanes, platinum plus fluoropyrimidinesBack to article page